Published Oct 24, 2026, 7:30 AM ET · Updated 20 days ago · 1 source
New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent
Wired
·
Original Report
INFERY
The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.